Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

Camp Victory: Support, Connections for Kids With Vitiligo

A unique camp brings together children and youth with vitiligo and their parents to talk about their challenges. They don’t want to leave.

Doctor Helps Woman Stop Blaming Herself and Accept Treatment

When an oncologist learns one patient’s story, everything shifts, including his approach to consultations.

IBS: New Dietetic Guidance Advises to ‘Think Beyond Diet’

Updated BDA guidance moves away from a diet-first approach to IBS, urging dietitians to consider lifestyle, mental health, and nondietary factors.

From K-pop to K-glow: Lasers, Face Firming Drive S Korea Tourism

Just over 2 million foreigners visited South Korea last year for medical treatment, nearly double the 2024 figure of ‌1.17 million.

Mohs for Rare Skin Cancer Linked to Lower Recurrence vs WLE

Mohs micrographic surgery reduces positive margins and 5-year recurrence in patients with dermatofibrosarcoma protuberans, compared with wide local excision, study finds.

The Potential for Remission, Cure in Psoriasis

'With the IL-23 blockers, for the first time ever, we've … seen a disconnect between drug levels in the blood and the ability to stay in remission,' says Andrew Blauvelt, MD.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Latest News

A unique camp brings together children and youth with vitiligo and their parents to talk about their challenges. They don’t want to leave.

When an oncologist learns one patient’s story, everything shifts, including his approach to consultations.

Updated BDA guidance moves away from a diet-first approach to IBS, urging dietitians to consider lifestyle, mental health, and nondietary factors.

Just over 2 million foreigners visited South Korea last year for medical treatment, nearly double the 2024 figure of ‌1.17 million.

Mohs micrographic surgery reduces positive margins and 5-year recurrence in patients with dermatofibrosarcoma protuberans, compared with wide local excision, study finds.

'With the IL-23 blockers, for the first time ever, we've … seen a disconnect between drug levels in the blood and the ability to stay in remission,' says Andrew Blauvelt, MD.

News All Time

Consider This Burnout Survey When Considering Your Specialty

Burnout is a problem in every specialty, but there’s high variability.

Isotretinoin Plus Laser Safe, Effective for Rhinophyma

Carbon dioxide laser resurfacing plus isotretinoin is safe and effective for treating rhinophyma, new research suggests, despite past warnings about combining the modalities.

Mohs Surgery With Narrower Margins Safe for Some MIS Cases

The two factors associated with needing larger final margins were older patient age and larger average preoperative tumor diameters, according to a single-center review of 530 primary MIS cases.

CO2 Laser Excision for Severe HS: Small Study Shows Benefits

The use of CO2 laser to excise lesions in patients with severe hidradenitis was effective and well-tolerated in a small retrospective review.

Adding Salicylic Acid to IPL Improves Rosacea Outcomes

Supramolecular salicylic acid plus intense pulsed light is associated with a greater reduction in rosacea-related erythema than intense pulsed light alone, in a prospective split-face study.

Does Risankizumab Show Lowest Infection Risk in Psoriasis?

A cohort analysis finds that risankizumab shows the lowest risk for serious infections compared to other systemic therapies in patients with psoriasis.

Obesity Drugs Linked to Lower Cancer Risk

Treatment with GLP-1 receptor agonists or dual GLP-1/ GIP receptor agonists is associated with reduced overall and skin cancer risks in people with obesity.

MHRA Strengthens Warnings on Finasteride and Dutasteride

The MHRA has updated product information for finasteride and dutasteride following a review of psychiatric and sexual side effects.

Rise in Global Skin Cancer Burden Projected to Continue

The global skin cancer burden has increased from 1990 to 2023 and is projected to rise through 2050, a database analysis shows.

Skin Cancer Location Potential Predictor of Poor Outcomes

Despite a higher incidence of poor outcomes with squamous cell carcinoma tumors on the scalp, it was the lip and temple that emerged as highest risk after adjustments for other factors.

Ultrafine Water Clusters Reduce Laser-Associated Erythema

A novel technology using nano-sized ultrafine water clusters is associated with significant reduction in the erythema that occurs post-laser treatment, new research shows.

A New Name for PCOS, the Most Common Cause Of Infertility

A disorder that affects 170 million women worldwide and is the leading cause of infertility known as polycystic ovary syndrome, ⁠or PCOS, is being renamed to improve...

Nail Unit SCC: Study Highlights Different Features

HPV and clinical features distinguish in situ vs invasive nail unit squamous cell carcinoma in a retrospective review.

High-Risk SCC: New Expert Guidelines for Adjuvant Radiation

The guidelines provide a starting place for conducting studies and collecting data to confirm what experts currently are recommending in the absence of adequate data.

Trump Says US FDA Commissioner Makary Is Out

U.S. FDA Commissioner Marty Makary resigned, President Donald Trump said on Tuesday, after weeks of clashing with top White House and health advisers and drawing scrutiny...

Chronic, Disfiguring Facial Rash With No Itching or Pain

Female patient reports low quality of life after 10 years of treatments with no response

Recommended News For You

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen

Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer

combating racial discrimination in next-generation breast cancer screening.

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy

Recommended Articles For You

Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics 

Exploring Innovative Approaches to Esophageal Cancer Treatment 

Emicizumab in Infants with Severe Hemophilia A: HAVEN 7 Phase 3b Trial Insights 

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

2.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

3.

Do I qualify for a cancer clinical trial?

4.

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

5.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

1.

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment

2.

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps

3.

Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment

4.

Cancer Rates on the Rise: What Can We Do to Stop It?

5.

Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot